Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + Atorvastatin vs Atorvastatin or Rosuvastatin in Hypercholesterolemia
NCT00871351Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in hypercholesterolemia (3 arms), sponsored by Organon & Co. Primary endpoint: Percent Change in Low-Density Lipoprotein - Cholesterol Values. Started Feb 2009; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00871351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871351.